| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera | 118 | 2024 | 747 | 16.860 |
Why?
|
| Vibrio cholerae O1 | 52 | 2024 | 243 | 10.160 |
Why?
|
| Antibodies, Bacterial | 85 | 2024 | 1468 | 10.040 |
Why?
|
| Cholera Vaccines | 49 | 2024 | 262 | 9.780 |
Why?
|
| O Antigens | 26 | 2024 | 196 | 7.900 |
Why?
|
| Typhoid Fever | 30 | 2023 | 195 | 6.300 |
Why?
|
| Vibrio cholerae | 56 | 2023 | 793 | 5.570 |
Why?
|
| Salmonella typhi | 25 | 2023 | 199 | 5.300 |
Why?
|
| Travel | 40 | 2024 | 785 | 4.260 |
Why?
|
| Bangladesh | 79 | 2023 | 728 | 3.610 |
Why?
|
| Vaccines, Conjugate | 14 | 2024 | 328 | 3.570 |
Why?
|
| Immunoglobulin A | 51 | 2024 | 979 | 3.480 |
Why?
|
| Dysentery, Bacillary | 7 | 2024 | 74 | 3.320 |
Why?
|
| Vibrio cholerae O139 | 14 | 2023 | 54 | 3.010 |
Why?
|
| Diarrhea | 31 | 2024 | 1319 | 2.880 |
Why?
|
| Immunologic Memory | 27 | 2022 | 1354 | 2.620 |
Why?
|
| Antigens, Bacterial | 24 | 2022 | 1155 | 2.590 |
Why?
|
| Immunoglobulin M | 27 | 2024 | 1529 | 2.420 |
Why?
|
| Immunoglobulin G | 62 | 2024 | 4541 | 2.390 |
Why?
|
| Vaccination | 38 | 2024 | 3361 | 2.310 |
Why?
|
| Shigella Vaccines | 3 | 2024 | 10 | 1.950 |
Why?
|
| Immunity, Mucosal | 11 | 2020 | 482 | 1.860 |
Why?
|
| Cholera Toxin | 34 | 2024 | 559 | 1.840 |
Why?
|
| Salmonella paratyphi A | 8 | 2017 | 47 | 1.710 |
Why?
|
| Travel Medicine | 9 | 2023 | 83 | 1.650 |
Why?
|
| Paratyphoid Fever | 6 | 2016 | 34 | 1.550 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 3 | 2020 | 39 | 1.500 |
Why?
|
| Bacteremia | 12 | 2015 | 980 | 1.460 |
Why?
|
| B-Lymphocytes | 26 | 2022 | 4742 | 1.390 |
Why?
|
| Shigella flexneri | 4 | 2024 | 119 | 1.360 |
Why?
|
| Shigella | 5 | 2023 | 69 | 1.330 |
Why?
|
| Immunity, Humoral | 5 | 2020 | 604 | 1.320 |
Why?
|
| Lipopolysaccharides | 22 | 2024 | 2209 | 1.280 |
Why?
|
| Communicable Disease Control | 9 | 2018 | 844 | 1.150 |
Why?
|
| Antibody-Producing Cells | 10 | 2021 | 140 | 1.080 |
Why?
|
| Endemic Diseases | 3 | 2024 | 190 | 1.010 |
Why?
|
| Feces | 20 | 2024 | 1455 | 1.000 |
Why?
|
| Parasitic Diseases | 4 | 2021 | 76 | 0.980 |
Why?
|
| Blood Group Antigens | 4 | 2023 | 187 | 0.980 |
Why?
|
| Antibody Formation | 12 | 2024 | 1400 | 0.970 |
Why?
|
| Disease Outbreaks | 15 | 2020 | 1758 | 0.970 |
Why?
|
| Shigella sonnei | 1 | 2024 | 7 | 0.970 |
Why?
|
| Salmonella Infections | 3 | 2015 | 171 | 0.950 |
Why?
|
| Vaccines, Combined | 2 | 2021 | 70 | 0.940 |
Why?
|
| Diarrhea, Infantile | 2 | 2015 | 101 | 0.930 |
Why?
|
| Child, Preschool | 74 | 2024 | 42063 | 0.900 |
Why?
|
| Escherichia coli Infections | 7 | 2018 | 523 | 0.900 |
Why?
|
| Communicable Diseases | 10 | 2018 | 878 | 0.900 |
Why?
|
| Serologic Tests | 5 | 2020 | 383 | 0.880 |
Why?
|
| Carrier State | 4 | 2021 | 525 | 0.870 |
Why?
|
| Antibodies, Viral | 16 | 2023 | 3143 | 0.850 |
Why?
|
| Bacterial Proteins | 13 | 2022 | 3826 | 0.770 |
Why?
|
| Tetanus Toxin | 3 | 2023 | 46 | 0.770 |
Why?
|
| Mucous Membrane | 5 | 2019 | 657 | 0.750 |
Why?
|
| Child | 86 | 2024 | 79806 | 0.730 |
Why?
|
| Virus Diseases | 4 | 2021 | 720 | 0.730 |
Why?
|
| Vaccines, Inactivated | 13 | 2023 | 180 | 0.720 |
Why?
|
| Administration, Oral | 22 | 2021 | 4035 | 0.720 |
Why?
|
| Salmonella | 4 | 2022 | 126 | 0.710 |
Why?
|
| Fever | 5 | 2024 | 1617 | 0.700 |
Why?
|
| Host-Pathogen Interactions | 6 | 2021 | 1447 | 0.700 |
Why?
|
| Bacterial Vaccines | 6 | 2009 | 401 | 0.690 |
Why?
|
| Humans | 265 | 2024 | 760621 | 0.690 |
Why?
|
| Enterotoxigenic Escherichia coli | 6 | 2018 | 32 | 0.670 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2019 | 586 | 0.650 |
Why?
|
| Adolescent | 89 | 2024 | 87810 | 0.630 |
Why?
|
| Vitreous Body | 3 | 2010 | 399 | 0.630 |
Why?
|
| Young Adult | 73 | 2024 | 58741 | 0.590 |
Why?
|
| Measles | 4 | 2022 | 185 | 0.580 |
Why?
|
| Enterotoxins | 5 | 2016 | 366 | 0.580 |
Why?
|
| Endophthalmitis | 3 | 2010 | 257 | 0.560 |
Why?
|
| Adult | 122 | 2024 | 219994 | 0.550 |
Why?
|
| Antifungal Agents | 1 | 2022 | 749 | 0.550 |
Why?
|
| Dehydration | 4 | 2022 | 216 | 0.550 |
Why?
|
| Disease Transmission, Infectious | 3 | 2018 | 558 | 0.540 |
Why?
|
| Vaccines | 6 | 2023 | 832 | 0.540 |
Why?
|
| Headache | 1 | 2024 | 1249 | 0.520 |
Why?
|
| Disasters | 3 | 2006 | 517 | 0.510 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 4 | 2022 | 72 | 0.510 |
Why?
|
| Immunization | 9 | 2020 | 1227 | 0.510 |
Why?
|
| Rubella | 3 | 2022 | 55 | 0.510 |
Why?
|
| Mumps | 3 | 2022 | 71 | 0.490 |
Why?
|
| Female | 140 | 2024 | 391270 | 0.490 |
Why?
|
| Plasma | 1 | 2018 | 584 | 0.480 |
Why?
|
| Anti-Bacterial Agents | 18 | 2023 | 7408 | 0.480 |
Why?
|
| Vaccines, Attenuated | 7 | 2022 | 314 | 0.480 |
Why?
|
| Bacterial Toxins | 6 | 2016 | 931 | 0.460 |
Why?
|
| Entamoebiasis | 1 | 2013 | 12 | 0.450 |
Why?
|
| Campylobacter Infections | 1 | 2013 | 31 | 0.450 |
Why?
|
| Vaccines, Synthetic | 7 | 2022 | 617 | 0.450 |
Why?
|
| Fimbriae Proteins | 8 | 2015 | 132 | 0.450 |
Why?
|
| Male | 124 | 2024 | 359744 | 0.450 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2016 | 611 | 0.440 |
Why?
|
| Pandemics | 12 | 2021 | 8624 | 0.440 |
Why?
|
| Infant | 41 | 2022 | 36060 | 0.440 |
Why?
|
| Eye Diseases | 2 | 2009 | 651 | 0.430 |
Why?
|
| Islam | 1 | 2014 | 71 | 0.430 |
Why?
|
| Blood | 4 | 2016 | 586 | 0.430 |
Why?
|
| Yellow Fever | 3 | 2021 | 54 | 0.420 |
Why?
|
| RNA, Bacterial | 2 | 2011 | 385 | 0.420 |
Why?
|
| Gallbladder | 1 | 2014 | 305 | 0.420 |
Why?
|
| Enterobacteriaceae | 4 | 2023 | 172 | 0.420 |
Why?
|
| Retinal Diseases | 2 | 2009 | 702 | 0.420 |
Why?
|
| Biliary Tract | 1 | 2013 | 135 | 0.420 |
Why?
|
| Rotavirus Infections | 1 | 2013 | 85 | 0.420 |
Why?
|
| Sarcocystidae | 1 | 2011 | 2 | 0.410 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2017 | 1827 | 0.410 |
Why?
|
| Coccidiosis | 1 | 2011 | 10 | 0.400 |
Why?
|
| Public Health Administration | 2 | 2013 | 243 | 0.390 |
Why?
|
| Bacterial Infections | 3 | 2017 | 1403 | 0.390 |
Why?
|
| Mice | 26 | 2024 | 81208 | 0.390 |
Why?
|
| Administration, Cutaneous | 5 | 2020 | 713 | 0.380 |
Why?
|
| Haiti | 9 | 2019 | 549 | 0.370 |
Why?
|
| Gastroenteritis | 1 | 2013 | 237 | 0.370 |
Why?
|
| Antibodies, Protozoan | 4 | 2012 | 251 | 0.370 |
Why?
|
| Animals | 44 | 2024 | 167963 | 0.360 |
Why?
|
| Glycoconjugates | 2 | 2023 | 88 | 0.350 |
Why?
|
| Middle Aged | 74 | 2022 | 220352 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9185 | 0.350 |
Why?
|
| Basketball | 2 | 2021 | 46 | 0.350 |
Why?
|
| Genome, Bacterial | 5 | 2024 | 770 | 0.350 |
Why?
|
| Family Characteristics | 8 | 2018 | 1001 | 0.340 |
Why?
|
| Malaria | 7 | 2017 | 1226 | 0.340 |
Why?
|
| Cryptosporidiosis | 4 | 2012 | 53 | 0.340 |
Why?
|
| Lymphocytes | 4 | 2022 | 2611 | 0.340 |
Why?
|
| Immunoassay | 3 | 2020 | 746 | 0.330 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2020 | 1055 | 0.320 |
Why?
|
| Salmonella typhimurium | 2 | 2009 | 344 | 0.320 |
Why?
|
| Convalescence | 3 | 2021 | 106 | 0.320 |
Why?
|
| Immunization Programs | 2 | 2018 | 268 | 0.310 |
Why?
|
| Antimalarials | 5 | 2016 | 906 | 0.310 |
Why?
|
| Internationality | 4 | 2024 | 1004 | 0.310 |
Why?
|
| Anti-Infective Agents | 3 | 2023 | 981 | 0.300 |
Why?
|
| Antibodies, Neutralizing | 6 | 2022 | 1933 | 0.290 |
Why?
|
| Blood Bactericidal Activity | 6 | 2015 | 126 | 0.290 |
Why?
|
| Bacillus anthracis | 1 | 2008 | 122 | 0.290 |
Why?
|
| Asia | 3 | 2018 | 620 | 0.290 |
Why?
|
| Fasting | 1 | 2014 | 1603 | 0.290 |
Why?
|
| Yellow Fever Vaccine | 2 | 2021 | 37 | 0.290 |
Why?
|
| Vitrectomy | 1 | 2010 | 391 | 0.290 |
Why?
|
| Leptin | 1 | 2015 | 1591 | 0.280 |
Why?
|
| Schistosomiasis mansoni | 1 | 2007 | 94 | 0.280 |
Why?
|
| Fungemia | 1 | 2007 | 58 | 0.270 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2015 | 1130 | 0.270 |
Why?
|
| Interferon-gamma | 2 | 2014 | 3157 | 0.270 |
Why?
|
| Cryptosporidium | 4 | 2012 | 41 | 0.270 |
Why?
|
| Neuraminidase | 3 | 2022 | 200 | 0.270 |
Why?
|
| Shigella dysenteriae | 1 | 2005 | 14 | 0.270 |
Why?
|
| Disease Models, Animal | 10 | 2023 | 18137 | 0.270 |
Why?
|
| Eye Infections, Bacterial | 2 | 2007 | 239 | 0.270 |
Why?
|
| Intestinal Diseases | 3 | 2016 | 506 | 0.260 |
Why?
|
| Gastrointestinal Tract | 3 | 2024 | 830 | 0.260 |
Why?
|
| Gene Expression Profiling | 9 | 2018 | 9411 | 0.260 |
Why?
|
| Proteome | 2 | 2013 | 1855 | 0.260 |
Why?
|
| Escherichia coli | 7 | 2023 | 4219 | 0.260 |
Why?
|
| Coronavirus Infections | 5 | 2020 | 3085 | 0.260 |
Why?
|
| Duodenum | 5 | 2022 | 486 | 0.260 |
Why?
|
| Proteomics | 6 | 2022 | 3817 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 5 | 2024 | 6216 | 0.260 |
Why?
|
| Salmonella enterica | 2 | 2016 | 75 | 0.260 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 3205 | 0.260 |
Why?
|
| Eye Infections, Fungal | 1 | 2007 | 100 | 0.260 |
Why?
|
| Onchocerciasis | 1 | 2005 | 28 | 0.260 |
Why?
|
| Immunization Schedule | 3 | 2023 | 224 | 0.260 |
Why?
|
| T-Lymphocytes | 6 | 2021 | 10181 | 0.250 |
Why?
|
| Lung Abscess | 1 | 2005 | 41 | 0.250 |
Why?
|
| Suture Techniques | 1 | 2010 | 790 | 0.250 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2005 | 106 | 0.250 |
Why?
|
| Weather | 1 | 2006 | 226 | 0.250 |
Why?
|
| Magnetite Nanoparticles | 2 | 2017 | 316 | 0.250 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2003 | 104 | 0.250 |
Why?
|
| Escherichia coli Proteins | 5 | 2016 | 1066 | 0.250 |
Why?
|
| Chromatography, Affinity | 3 | 2020 | 534 | 0.250 |
Why?
|
| Insect Bites and Stings | 2 | 2018 | 70 | 0.240 |
Why?
|
| Microsurgery | 1 | 2010 | 796 | 0.240 |
Why?
|
| Treatment Refusal | 3 | 2017 | 430 | 0.240 |
Why?
|
| Intestines | 7 | 2016 | 1907 | 0.240 |
Why?
|
| Immunologic Techniques | 1 | 2005 | 213 | 0.240 |
Why?
|
| Bacteriological Techniques | 2 | 2018 | 279 | 0.240 |
Why?
|
| Brain Abscess | 1 | 2005 | 120 | 0.240 |
Why?
|
| Pakistan | 3 | 2023 | 304 | 0.240 |
Why?
|
| Specimen Handling | 2 | 2020 | 707 | 0.240 |
Why?
|
| Rabbits | 6 | 2023 | 4773 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2024 | 3986 | 0.230 |
Why?
|
| Pneumonia, Aspiration | 1 | 2005 | 146 | 0.230 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2023 | 192 | 0.230 |
Why?
|
| Antibody Affinity | 3 | 2014 | 245 | 0.230 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 377 | 0.230 |
Why?
|
| Paresis | 1 | 2005 | 177 | 0.230 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 386 | 0.230 |
Why?
|
| Occupational Health | 2 | 2016 | 805 | 0.230 |
Why?
|
| Colistin | 2 | 2023 | 44 | 0.220 |
Why?
|
| Disease Susceptibility | 4 | 2021 | 1791 | 0.220 |
Why?
|
| Hafnia | 1 | 2023 | 3 | 0.220 |
Why?
|
| Pneumonia | 1 | 2015 | 2131 | 0.220 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 2003 | 7 | 0.220 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5496 | 0.220 |
Why?
|
| Yersinia pestis | 1 | 2003 | 33 | 0.220 |
Why?
|
| Plague | 1 | 2003 | 20 | 0.220 |
Why?
|
| Phylogeny | 6 | 2024 | 2775 | 0.220 |
Why?
|
| Antitoxins | 3 | 2019 | 77 | 0.210 |
Why?
|
| Syphilis | 1 | 2005 | 241 | 0.210 |
Why?
|
| Carbapenems | 2 | 2023 | 123 | 0.210 |
Why?
|
| United States | 28 | 2024 | 72461 | 0.210 |
Why?
|
| Antibody Specificity | 4 | 2021 | 1060 | 0.210 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2013 | 3164 | 0.210 |
Why?
|
| Bioterrorism | 1 | 2003 | 144 | 0.210 |
Why?
|
| Peru | 2 | 2024 | 869 | 0.200 |
Why?
|
| Enzyme-Linked Immunospot Assay | 3 | 2017 | 123 | 0.200 |
Why?
|
| Antigens, Protozoan | 3 | 2012 | 316 | 0.200 |
Why?
|
| Genetic Vectors | 4 | 2000 | 3380 | 0.200 |
Why?
|
| Seasons | 3 | 2023 | 1522 | 0.200 |
Why?
|
| History, 21st Century | 3 | 2018 | 1575 | 0.200 |
Why?
|
| Protein Array Analysis | 2 | 2013 | 401 | 0.200 |
Why?
|
| Adjuvants, Immunologic | 3 | 2020 | 1039 | 0.190 |
Why?
|
| Developing Countries | 9 | 2014 | 2868 | 0.190 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2018 | 1810 | 0.190 |
Why?
|
| Adhesins, Bacterial | 2 | 1999 | 118 | 0.190 |
Why?
|
| Entamoeba histolytica | 2 | 2000 | 29 | 0.190 |
Why?
|
| Sensitivity and Specificity | 13 | 2020 | 14660 | 0.190 |
Why?
|
| Anthozoa | 1 | 2021 | 65 | 0.190 |
Why?
|
| Agglutination | 1 | 2020 | 41 | 0.190 |
Why?
|
| Cross Reactions | 5 | 2022 | 818 | 0.190 |
Why?
|
| Primary Health Care | 1 | 2018 | 4647 | 0.190 |
Why?
|
| Animals, Suckling | 1 | 2020 | 69 | 0.190 |
Why?
|
| Eosinophilia | 1 | 2005 | 559 | 0.190 |
Why?
|
| Immunity, Innate | 4 | 2019 | 3047 | 0.180 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
| RNA, Messenger | 7 | 2023 | 12766 | 0.180 |
Why?
|
| Altitude Sickness | 2 | 2018 | 91 | 0.180 |
Why?
|
| Immunization, Secondary | 2 | 2021 | 368 | 0.180 |
Why?
|
| Hemolysin Proteins | 2 | 2017 | 114 | 0.180 |
Why?
|
| Nucleocapsid Proteins | 1 | 2020 | 76 | 0.180 |
Why?
|
| Diagnosis, Differential | 9 | 2021 | 12965 | 0.180 |
Why?
|
| Peroxidase | 2 | 2021 | 605 | 0.180 |
Why?
|
| Neurocysticercosis | 1 | 2021 | 91 | 0.180 |
Why?
|
| Contact Tracing | 2 | 2014 | 268 | 0.180 |
Why?
|
| Shiga Toxins | 2 | 1999 | 40 | 0.180 |
Why?
|
| Genetic Variation | 4 | 2024 | 6551 | 0.170 |
Why?
|
| Plasmids | 3 | 2017 | 2275 | 0.170 |
Why?
|
| Athletic Injuries | 2 | 2021 | 1209 | 0.170 |
Why?
|
| Chemoprevention | 3 | 2023 | 326 | 0.170 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2000 | 72 | 0.170 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
| Laboratories, Hospital | 1 | 2021 | 193 | 0.170 |
Why?
|
| Hospitals | 7 | 2020 | 3928 | 0.170 |
Why?
|
| Accidents, Traffic | 2 | 2018 | 814 | 0.170 |
Why?
|
| Serotyping | 4 | 2015 | 324 | 0.170 |
Why?
|
| Metagenomics | 2 | 2021 | 457 | 0.170 |
Why?
|
| Tuberculosis, Cutaneous | 1 | 2019 | 17 | 0.160 |
Why?
|
| Intestinal Mucosa | 4 | 2022 | 3022 | 0.160 |
Why?
|
| Microbial Viability | 4 | 2020 | 238 | 0.160 |
Why?
|
| Nepal | 3 | 2018 | 301 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2023 | 1949 | 0.160 |
Why?
|
| Antigens | 1 | 2005 | 1447 | 0.160 |
Why?
|
| Health Behavior | 1 | 2010 | 2622 | 0.160 |
Why?
|
| Polysaccharides, Bacterial | 2 | 2020 | 574 | 0.160 |
Why?
|
| Antibiosis | 1 | 2018 | 45 | 0.160 |
Why?
|
| Preventive Medicine | 1 | 2000 | 250 | 0.160 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 926 | 0.150 |
Why?
|
| Lung | 3 | 2007 | 9994 | 0.150 |
Why?
|
| Molecular Epidemiology | 2 | 2018 | 469 | 0.150 |
Why?
|
| Immune Evasion | 1 | 2022 | 362 | 0.150 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2023 | 508 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 749 | 0.150 |
Why?
|
| History, 20th Century | 2 | 2018 | 2773 | 0.150 |
Why?
|
| Barotrauma | 1 | 2018 | 39 | 0.150 |
Why?
|
| Food Safety | 1 | 2018 | 22 | 0.150 |
Why?
|
| Desiccation | 1 | 2018 | 78 | 0.150 |
Why?
|
| Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.150 |
Why?
|
| Protozoan Vaccines | 1 | 1997 | 13 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 3484 | 0.150 |
Why?
|
| Ships | 1 | 2018 | 53 | 0.150 |
Why?
|
| Retina | 1 | 2009 | 2635 | 0.150 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2021 | 330 | 0.150 |
Why?
|
| Molecular Typing | 2 | 2015 | 116 | 0.150 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.150 |
Why?
|
| Athletic Performance | 1 | 2018 | 105 | 0.150 |
Why?
|
| Cervix Uteri | 1 | 2001 | 582 | 0.150 |
Why?
|
| Receptors, IgG | 1 | 2020 | 559 | 0.140 |
Why?
|
| Pneumonia, Bacterial | 1 | 2000 | 319 | 0.140 |
Why?
|
| Aircraft | 1 | 2018 | 126 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2020 | 658 | 0.140 |
Why?
|
| Cyclobutanes | 1 | 2017 | 57 | 0.140 |
Why?
|
| Insect Repellents | 1 | 2016 | 17 | 0.140 |
Why?
|
| Mosquito Nets | 1 | 2016 | 9 | 0.140 |
Why?
|
| Zoonoses | 1 | 2018 | 179 | 0.140 |
Why?
|
| Flagellin | 1 | 2017 | 124 | 0.140 |
Why?
|
| Antigens, Viral | 1 | 2020 | 980 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 415 | 0.140 |
Why?
|
| Bacterial Typing Techniques | 2 | 2014 | 260 | 0.140 |
Why?
|
| beta-Lactamases | 3 | 2023 | 304 | 0.130 |
Why?
|
| Medicine | 2 | 2023 | 943 | 0.130 |
Why?
|
| Protective Clothing | 1 | 2016 | 103 | 0.130 |
Why?
|
| North America | 1 | 2019 | 1284 | 0.130 |
Why?
|
| Eye Infections, Parasitic | 1 | 1996 | 25 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 766 | 0.130 |
Why?
|
| HLA-DR Antigens | 1 | 2017 | 630 | 0.130 |
Why?
|
| Risk Factors | 17 | 2023 | 74359 | 0.130 |
Why?
|
| Health Services Misuse | 1 | 2017 | 245 | 0.130 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2018 | 628 | 0.130 |
Why?
|
| Risk Assessment | 12 | 2018 | 24123 | 0.130 |
Why?
|
| Hybridization, Genetic | 1 | 2015 | 103 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 4573 | 0.130 |
Why?
|
| Geography | 1 | 2018 | 661 | 0.130 |
Why?
|
| Geographic Information Systems | 1 | 2018 | 280 | 0.130 |
Why?
|
| Age Factors | 5 | 2021 | 18416 | 0.130 |
Why?
|
| Immunologic Tests | 1 | 2016 | 103 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 5 | 2022 | 5508 | 0.130 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 115 | 0.130 |
Why?
|
| Infant, Newborn | 13 | 2024 | 26181 | 0.130 |
Why?
|
| DNA Probes | 1 | 2016 | 551 | 0.130 |
Why?
|
| Probiotics | 1 | 2019 | 377 | 0.120 |
Why?
|
| Severity of Illness Index | 7 | 2022 | 15840 | 0.120 |
Why?
|
| Dominican Republic | 2 | 2012 | 74 | 0.120 |
Why?
|
| Infant Nutrition Disorders | 1 | 2015 | 70 | 0.120 |
Why?
|
| Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
| Japanese Encephalitis Vaccines | 1 | 2014 | 7 | 0.120 |
Why?
|
| Case-Control Studies | 9 | 2019 | 22053 | 0.120 |
Why?
|
| Anterior Eye Segment | 1 | 1996 | 141 | 0.120 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2014 | 12 | 0.120 |
Why?
|
| Encephalitis, Japanese | 1 | 2014 | 13 | 0.120 |
Why?
|
| Aged | 26 | 2024 | 169152 | 0.120 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2014 | 24 | 0.120 |
Why?
|
| Epidemics | 2 | 2018 | 510 | 0.120 |
Why?
|
| Albendazole | 1 | 2014 | 50 | 0.120 |
Why?
|
| Dengue | 1 | 2017 | 254 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 84 | 0.120 |
Why?
|
| Acute Disease | 6 | 2018 | 7269 | 0.120 |
Why?
|
| Rabies Vaccines | 1 | 2013 | 27 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2020 | 3804 | 0.110 |
Why?
|
| Leisure Activities | 1 | 2016 | 306 | 0.110 |
Why?
|
| Cohort Studies | 16 | 2022 | 41335 | 0.110 |
Why?
|
| Exanthema | 1 | 2019 | 504 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2020 | 3735 | 0.110 |
Why?
|
| Lectins | 1 | 2016 | 484 | 0.110 |
Why?
|
| Haplotypes | 2 | 2018 | 2764 | 0.110 |
Why?
|
| History, 16th Century | 1 | 2013 | 70 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 2 | 2017 | 323 | 0.110 |
Why?
|
| Rabies | 1 | 2013 | 53 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2002 | 1089 | 0.110 |
Why?
|
| History, 17th Century | 1 | 2013 | 107 | 0.110 |
Why?
|
| Protozoan Proteins | 2 | 2011 | 839 | 0.110 |
Why?
|
| Hospitalization | 5 | 2021 | 10790 | 0.110 |
Why?
|
| Peptides | 2 | 2020 | 4354 | 0.110 |
Why?
|
| AIDS Vaccines | 1 | 2020 | 895 | 0.110 |
Why?
|
| Occupational Exposure | 1 | 2004 | 1809 | 0.110 |
Why?
|
| Prophages | 1 | 2013 | 38 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2016 | 6538 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 975 | 0.110 |
Why?
|
| History, 18th Century | 1 | 2013 | 207 | 0.110 |
Why?
|
| Child Nutrition Disorders | 1 | 2014 | 150 | 0.110 |
Why?
|
| Rural Population | 3 | 2018 | 2268 | 0.110 |
Why?
|
| Peptide Hydrolases | 1 | 2016 | 623 | 0.110 |
Why?
|
| Nucleic Acids | 1 | 2015 | 188 | 0.110 |
Why?
|
| Pregnant Women | 1 | 2017 | 563 | 0.100 |
Why?
|
| Time Factors | 12 | 2020 | 40165 | 0.100 |
Why?
|
| Biosensing Techniques | 2 | 2017 | 677 | 0.100 |
Why?
|
| HIV Infections | 3 | 2017 | 17165 | 0.100 |
Why?
|
| Family Health | 3 | 2018 | 1257 | 0.100 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2014 | 173 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2022 | 2326 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1190 | 0.100 |
Why?
|
| Environmental Illness | 1 | 2012 | 34 | 0.100 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2015 | 491 | 0.100 |
Why?
|
| Cholecystectomy | 1 | 2014 | 406 | 0.100 |
Why?
|
| Virulence | 3 | 2015 | 1298 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2023 | 1528 | 0.100 |
Why?
|
| Health Planning Guidelines | 1 | 2012 | 151 | 0.100 |
Why?
|
| Protozoan Infections | 1 | 2011 | 39 | 0.100 |
Why?
|
| Urban Population | 3 | 2015 | 2022 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2020 | 728 | 0.100 |
Why?
|
| Ileus | 1 | 2011 | 57 | 0.100 |
Why?
|
| Viral Load | 4 | 2022 | 3322 | 0.100 |
Why?
|
| Immunocompromised Host | 2 | 2015 | 857 | 0.100 |
Why?
|
| Incidence | 8 | 2022 | 21392 | 0.100 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 58995 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1204 | 0.090 |
Why?
|
| Sanitation | 1 | 2011 | 85 | 0.090 |
Why?
|
| Cholecystitis | 1 | 1992 | 181 | 0.090 |
Why?
|
| Malnutrition | 2 | 2014 | 640 | 0.090 |
Why?
|
| Rivers | 2 | 2013 | 66 | 0.090 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2017 | 831 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2013 | 720 | 0.090 |
Why?
|
| Safety | 1 | 2015 | 1148 | 0.090 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 241 | 0.090 |
Why?
|
| Ciprofloxacin | 1 | 2013 | 312 | 0.090 |
Why?
|
| Germ-Free Life | 3 | 2000 | 187 | 0.090 |
Why?
|
| Plasmodium falciparum | 1 | 2001 | 1742 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 2192 | 0.090 |
Why?
|
| Hypokalemia | 1 | 2011 | 152 | 0.090 |
Why?
|
| Aviation | 1 | 2010 | 49 | 0.090 |
Why?
|
| Commerce | 1 | 2016 | 605 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 20080 | 0.090 |
Why?
|
| Paralysis | 1 | 2011 | 251 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5785 | 0.090 |
Why?
|
| Monocytes | 1 | 2019 | 2575 | 0.090 |
Why?
|
| Hirschsprung Disease | 1 | 1992 | 163 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2010 | 15697 | 0.090 |
Why?
|
| Arthritis, Reactive | 1 | 2009 | 20 | 0.090 |
Why?
|
| Minisatellite Repeats | 1 | 2010 | 164 | 0.080 |
Why?
|
| Species Specificity | 2 | 2015 | 2418 | 0.080 |
Why?
|
| Cytokines | 5 | 2019 | 7343 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2013 | 18957 | 0.080 |
Why?
|
| Incontinentia Pigmenti | 1 | 2009 | 12 | 0.080 |
Why?
|
| Population Density | 1 | 2010 | 192 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7850 | 0.080 |
Why?
|
| Demography | 4 | 2015 | 1650 | 0.080 |
Why?
|
| Breast Feeding | 1 | 2017 | 1355 | 0.080 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 7806 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.080 |
Why?
|
| Seizures | 1 | 2021 | 2917 | 0.080 |
Why?
|
| Fluid Therapy | 2 | 2012 | 579 | 0.080 |
Why?
|
| Metagenome | 2 | 2023 | 450 | 0.080 |
Why?
|
| Foodborne Diseases | 1 | 2008 | 40 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 1999 | 4938 | 0.080 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 25942 | 0.080 |
Why?
|
| Macaca mulatta | 2 | 2021 | 2316 | 0.080 |
Why?
|
| Floods | 1 | 2008 | 41 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2013 | 653 | 0.080 |
Why?
|
| Helminthiasis | 1 | 2009 | 80 | 0.080 |
Why?
|
| Fimbriae, Bacterial | 2 | 2005 | 138 | 0.080 |
Why?
|
| Hygiene | 1 | 2008 | 94 | 0.080 |
Why?
|
| Counseling | 2 | 2015 | 1548 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2015 | 1207 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 747 | 0.070 |
Why?
|
| Bartonella | 1 | 2007 | 11 | 0.070 |
Why?
|
| Pregnancy | 6 | 2023 | 29749 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2009 | 2049 | 0.070 |
Why?
|
| Bartonella Infections | 1 | 2007 | 21 | 0.070 |
Why?
|
| Toxoids | 1 | 2007 | 11 | 0.070 |
Why?
|
| Rotavirus | 1 | 2008 | 110 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 786 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1913 | 0.070 |
Why?
|
| World Health Organization | 1 | 2013 | 1312 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2640 | 0.070 |
Why?
|
| Proteins | 2 | 2013 | 6029 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2010 | 1991 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3486 | 0.070 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 12159 | 0.070 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2007 | 83 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2017 | 2125 | 0.070 |
Why?
|
| Primaquine | 1 | 2006 | 28 | 0.070 |
Why?
|
| Conjunctiva | 1 | 2010 | 479 | 0.070 |
Why?
|
| Tropical Medicine | 2 | 2004 | 51 | 0.070 |
Why?
|
| Lovastatin | 1 | 2006 | 116 | 0.070 |
Why?
|
| Schistosoma mansoni | 1 | 2007 | 156 | 0.070 |
Why?
|
| Length of Stay | 1 | 2000 | 6479 | 0.070 |
Why?
|
| Telemedicine | 1 | 2024 | 3018 | 0.070 |
Why?
|
| Filaricides | 1 | 2005 | 10 | 0.070 |
Why?
|
| Penicillin G Benzathine | 1 | 2005 | 25 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3616 | 0.070 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2005 | 37 | 0.070 |
Why?
|
| Shiga Toxin | 1 | 2005 | 36 | 0.060 |
Why?
|
| Mass Screening | 1 | 2022 | 5423 | 0.060 |
Why?
|
| Ivermectin | 1 | 2005 | 46 | 0.060 |
Why?
|
| Advisory Committees | 2 | 2022 | 788 | 0.060 |
Why?
|
| Epitopes | 2 | 2022 | 2503 | 0.060 |
Why?
|
| Th17 Cells | 3 | 2022 | 787 | 0.060 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2018 | 238 | 0.060 |
Why?
|
| Gastritis | 1 | 2007 | 198 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2380 | 0.060 |
Why?
|
| Prevalence | 4 | 2018 | 15687 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2018 | 6068 | 0.060 |
Why?
|
| Aphasia, Broca | 1 | 2005 | 52 | 0.060 |
Why?
|
| Tanzania | 1 | 2010 | 1383 | 0.060 |
Why?
|
| Rectum | 2 | 2009 | 895 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 1999 | 407 | 0.060 |
Why?
|
| Indonesia | 1 | 2005 | 127 | 0.060 |
Why?
|
| Bacillus | 1 | 2005 | 78 | 0.060 |
Why?
|
| Empyema, Pleural | 1 | 2005 | 61 | 0.060 |
Why?
|
| Skin | 1 | 2019 | 4466 | 0.060 |
Why?
|
| Sex Factors | 2 | 2017 | 10547 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2477 | 0.060 |
Why?
|
| Gene Library | 2 | 2005 | 1060 | 0.060 |
Why?
|
| Eye | 1 | 2009 | 710 | 0.060 |
Why?
|
| Mycobacterium smegmatis | 1 | 2005 | 124 | 0.060 |
Why?
|
| Retinal Detachment | 1 | 2009 | 427 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 1992 | 1415 | 0.060 |
Why?
|
| Retinopathy of Prematurity | 1 | 2009 | 432 | 0.060 |
Why?
|
| Aortography | 1 | 2005 | 420 | 0.060 |
Why?
|
| Decision Making | 1 | 2018 | 3925 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12427 | 0.060 |
Why?
|
| Zinc | 3 | 2017 | 689 | 0.060 |
Why?
|
| Disease Progression | 1 | 2020 | 13502 | 0.060 |
Why?
|
| Epidemiologic Methods | 2 | 2018 | 1343 | 0.060 |
Why?
|
| Boston | 2 | 2020 | 9280 | 0.060 |
Why?
|
| Echinococcus | 1 | 2003 | 16 | 0.050 |
Why?
|
| Retinal Vein Occlusion | 1 | 2005 | 149 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1557 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20509 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2011 | 9287 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3775 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2018 | 23376 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5397 | 0.050 |
Why?
|
| Retinal Vessels | 1 | 2009 | 836 | 0.050 |
Why?
|
| Liver | 1 | 2019 | 7509 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2012 | 1540 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2018 | 3426 | 0.050 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2002 | 13 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2023 | 54303 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3224 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2024 | 80372 | 0.050 |
Why?
|
| Hemorrhagic Fevers, Viral | 1 | 2002 | 23 | 0.050 |
Why?
|
| Antibodies | 2 | 2021 | 2421 | 0.050 |
Why?
|
| Trypanosomiasis, African | 1 | 2002 | 30 | 0.050 |
Why?
|
| Antacids | 1 | 2022 | 94 | 0.050 |
Why?
|
| HIV-1 | 1 | 2020 | 6849 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4353 | 0.050 |
Why?
|
| Knowledge | 1 | 2024 | 176 | 0.050 |
Why?
|
| Radiography | 2 | 2011 | 6965 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1131 | 0.050 |
Why?
|
| beta-Lactams | 1 | 2023 | 157 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3568 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2315 | 0.050 |
Why?
|
| Central Nervous System Infections | 1 | 2002 | 61 | 0.050 |
Why?
|
| DNA, Bacterial | 3 | 2014 | 1456 | 0.050 |
Why?
|
| Pneumothorax | 1 | 2005 | 379 | 0.050 |
Why?
|
| Th1 Cells | 3 | 2012 | 1032 | 0.050 |
Why?
|
| Azithromycin | 1 | 2023 | 200 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2022 | 169 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2020 | 2440 | 0.050 |
Why?
|
| Poverty | 1 | 2013 | 2695 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7818 | 0.050 |
Why?
|
| Th2 Cells | 3 | 2012 | 1047 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2022 | 1885 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 394 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2015 | 10446 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2023 | 388 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 14495 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2005 | 567 | 0.050 |
Why?
|
| Microbial Interactions | 1 | 2021 | 74 | 0.050 |
Why?
|
| Biopsy | 3 | 2019 | 6771 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 8552 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 1544 | 0.050 |
Why?
|
| Environmental Exposure | 2 | 2013 | 4412 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17790 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2021 | 337 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4291 | 0.050 |
Why?
|
| Health Surveys | 1 | 2010 | 4063 | 0.040 |
Why?
|
| Intubation | 1 | 2020 | 139 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2023 | 856 | 0.040 |
Why?
|
| Abdominal Pain | 2 | 2019 | 1063 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2017 | 2569 | 0.040 |
Why?
|
| Africa | 2 | 2018 | 705 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2000 | 161 | 0.040 |
Why?
|
| Health Personnel | 1 | 2014 | 3310 | 0.040 |
Why?
|
| Sodium Acetate | 1 | 2019 | 7 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2020 | 363 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2009 | 2256 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2013 | 8035 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2020 | 280 | 0.040 |
Why?
|
| Colony Count, Microbial | 2 | 2012 | 328 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2021 | 437 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 418 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2001 | 254 | 0.040 |
Why?
|
| Lipid A | 1 | 2019 | 70 | 0.040 |
Why?
|
| Public Health | 1 | 2012 | 2653 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 900 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2019 | 206 | 0.040 |
Why?
|
| Awareness | 1 | 2023 | 646 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 555 | 0.040 |
Why?
|
| Health Status | 1 | 2012 | 4081 | 0.040 |
Why?
|
| Inflammasomes | 2 | 2015 | 530 | 0.040 |
Why?
|
| Eosinophils | 1 | 2004 | 944 | 0.040 |
Why?
|
| Plasmodium vivax | 1 | 2001 | 202 | 0.040 |
Why?
|
| Models, Biological | 2 | 2019 | 9467 | 0.040 |
Why?
|
| Brain | 2 | 2021 | 26951 | 0.040 |
Why?
|
| Endotoxins | 1 | 2021 | 521 | 0.040 |
Why?
|
| Biotechnology | 1 | 2020 | 281 | 0.040 |
Why?
|
| Delivery of Health Care | 2 | 2015 | 5325 | 0.040 |
Why?
|
| Culture Media | 1 | 2020 | 900 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2021 | 1649 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2019 | 665 | 0.040 |
Why?
|
| Endometriosis | 1 | 2006 | 874 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 267 | 0.040 |
Why?
|
| Disease Notification | 1 | 2018 | 97 | 0.040 |
Why?
|
| Sudan | 1 | 2018 | 86 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 11903 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2001 | 742 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 1006 | 0.040 |
Why?
|
| Aorta | 1 | 2005 | 2039 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 642 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4713 | 0.040 |
Why?
|
| Physical Examination | 1 | 2004 | 1244 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 3765 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 22023 | 0.040 |
Why?
|
| Viremia | 1 | 2020 | 707 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2021 | 9716 | 0.040 |
Why?
|
| Massachusetts | 2 | 2020 | 8803 | 0.040 |
Why?
|
| Family | 3 | 2015 | 3189 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 1423 | 0.040 |
Why?
|
| Dyspnea | 1 | 2005 | 1352 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2020 | 943 | 0.040 |
Why?
|
| Americas | 1 | 2017 | 111 | 0.040 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2017 | 144 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2022 | 1982 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2018 | 521 | 0.040 |
Why?
|
| Consciousness Disorders | 1 | 2021 | 440 | 0.030 |
Why?
|
| Biostatistics | 1 | 2018 | 164 | 0.030 |
Why?
|
| Glutamine | 1 | 2000 | 576 | 0.030 |
Why?
|
| Specialization | 1 | 2021 | 778 | 0.030 |
Why?
|
| Hybridomas | 1 | 2017 | 442 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15757 | 0.030 |
Why?
|
| Dependovirus | 1 | 2021 | 709 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 2017 | 859 | 0.030 |
Why?
|
| Water | 1 | 2022 | 1407 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 17624 | 0.030 |
Why?
|
| Synteny | 1 | 2015 | 77 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2000 | 1071 | 0.030 |
Why?
|
| Oxides | 1 | 2017 | 401 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2117 | 0.030 |
Why?
|
| Age Distribution | 2 | 2014 | 2893 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 169 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.030 |
Why?
|
| Mutation | 3 | 2022 | 29932 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 2015 | 140 | 0.030 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1016 | 0.030 |
Why?
|
| Vitamin A | 2 | 2008 | 613 | 0.030 |
Why?
|
| Bacteria | 1 | 2006 | 2199 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 57 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 533 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6218 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1999 | 1234 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 998 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1636 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 13451 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 2005 | 1150 | 0.030 |
Why?
|
| Spirometry | 1 | 2017 | 924 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2015 | 80 | 0.030 |
Why?
|
| Comorbidity | 2 | 2020 | 10551 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 726 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10182 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 619 | 0.030 |
Why?
|
| Malabsorption Syndromes | 1 | 2014 | 135 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3301 | 0.030 |
Why?
|
| Temperature | 1 | 2020 | 2221 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2014 | 151 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 381 | 0.030 |
Why?
|
| Africa, Western | 1 | 2013 | 159 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3598 | 0.030 |
Why?
|
| Computational Biology | 1 | 2005 | 3505 | 0.030 |
Why?
|
| Yellow fever virus | 1 | 2013 | 23 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 787 | 0.030 |
Why?
|
| Parasites | 1 | 1996 | 161 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 2019 | 520 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 432 | 0.030 |
Why?
|
| Genotype | 3 | 2015 | 12960 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2722 | 0.030 |
Why?
|
| Uganda | 1 | 2017 | 1324 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2019 | 1435 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1607 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 1809 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2005 | 5961 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 587 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2013 | 288 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1594 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 2502 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 1296 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2020 | 2838 | 0.030 |
Why?
|
| Cryptosporidium parvum | 1 | 2012 | 35 | 0.020 |
Why?
|
| Logistic Models | 3 | 2012 | 13314 | 0.020 |
Why?
|
| Genomics | 2 | 2018 | 5794 | 0.020 |
Why?
|
| Altruism | 1 | 2014 | 205 | 0.020 |
Why?
|
| Cell Separation | 1 | 2017 | 1720 | 0.020 |
Why?
|
| Friends | 1 | 2013 | 150 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1392 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1879 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2022 | 5434 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 506 | 0.020 |
Why?
|
| Birth Order | 1 | 1992 | 95 | 0.020 |
Why?
|
| Pedigree | 2 | 2009 | 4578 | 0.020 |
Why?
|
| Occupations | 1 | 2013 | 515 | 0.020 |
Why?
|
| Cattle | 1 | 2017 | 3847 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 580 | 0.020 |
Why?
|
| Kinetics | 1 | 2019 | 6377 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2011 | 98 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 39261 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5870 | 0.020 |
Why?
|
| Public Health Informatics | 1 | 2011 | 109 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 956 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1021 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3215 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1992 | 11891 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2011 | 228 | 0.020 |
Why?
|
| Diet | 1 | 2008 | 8010 | 0.020 |
Why?
|
| Intestine, Small | 2 | 2007 | 1207 | 0.020 |
Why?
|
| Morbidity | 1 | 1996 | 1765 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29658 | 0.020 |
Why?
|
| Nigeria | 1 | 2013 | 762 | 0.020 |
Why?
|
| Erythromycin | 1 | 2010 | 117 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 2009 | 63 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 296 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7233 | 0.020 |
Why?
|
| Protein Binding | 1 | 2022 | 9335 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8555 | 0.020 |
Why?
|
| Tetracycline | 1 | 2010 | 220 | 0.020 |
Why?
|
| Iron | 1 | 2017 | 1786 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2014 | 619 | 0.020 |
Why?
|
| Neutrophils | 1 | 2022 | 3767 | 0.020 |
Why?
|
| Hypergammaglobulinemia | 1 | 1988 | 72 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3839 | 0.020 |
Why?
|
| Maternal Age | 1 | 1992 | 807 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2018 | 1940 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2013 | 869 | 0.020 |
Why?
|
| Recurrence | 2 | 2014 | 8482 | 0.020 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 82 | 0.020 |
Why?
|
| Serum | 1 | 2009 | 211 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2019 | 65017 | 0.020 |
Why?
|
| Gaucher Disease | 1 | 1988 | 110 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 1988 | 119 | 0.020 |
Why?
|
| Internet | 1 | 2000 | 3078 | 0.020 |
Why?
|
| Bacteriolysis | 1 | 2007 | 51 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 2176 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2007 | 234 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2005 | 4555 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3736 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 877 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1242 | 0.020 |
Why?
|
| Gene Expression | 1 | 2000 | 7588 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2007 | 189 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 1074 | 0.020 |
Why?
|
| Serum Bactericidal Test | 1 | 2005 | 3 | 0.020 |
Why?
|
| Societies | 1 | 2006 | 108 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2012 | 539 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 6189 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 2105 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 151 | 0.020 |
Why?
|
| Sleep | 1 | 2021 | 4751 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 3 | 2014 | 7475 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5039 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2006 | 210 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15289 | 0.020 |
Why?
|
| Chest Pain | 1 | 1992 | 1106 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2488 | 0.010 |
Why?
|
| Bacterial Capsules | 1 | 2005 | 242 | 0.010 |
Why?
|
| Bacteriophages | 1 | 2007 | 372 | 0.010 |
Why?
|
| Military Personnel | 1 | 2013 | 1244 | 0.010 |
Why?
|
| Base Sequence | 1 | 2015 | 12446 | 0.010 |
Why?
|
| Mucins | 1 | 2007 | 568 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5125 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2698 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 1996 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2283 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 176 | 0.010 |
Why?
|
| Birth Weight | 1 | 1992 | 2097 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4925 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 2003 | 113 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13262 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1763 | 0.010 |
Why?
|
| Gestational Age | 1 | 1992 | 3565 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2295 | 0.010 |
Why?
|
| Suramin | 1 | 2002 | 34 | 0.010 |
Why?
|
| Compartment Syndromes | 1 | 2005 | 158 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 2005 | 532 | 0.010 |
Why?
|
| Microscopy | 1 | 2007 | 885 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4166 | 0.010 |
Why?
|
| Mannose-Binding Lectin | 1 | 2003 | 146 | 0.010 |
Why?
|
| Trypanocidal Agents | 1 | 2002 | 41 | 0.010 |
Why?
|
| Foot Dermatoses | 1 | 2002 | 47 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2717 | 0.010 |
Why?
|
| Multigene Family | 1 | 2005 | 1077 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2009 | 3615 | 0.010 |
Why?
|
| Anthrax | 1 | 2002 | 88 | 0.010 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2002 | 68 | 0.010 |
Why?
|
| Virulence Factors | 1 | 2005 | 511 | 0.010 |
Why?
|
| Drug Design | 1 | 2006 | 1061 | 0.010 |
Why?
|
| Erythema | 1 | 2002 | 262 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10756 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 2002 | 281 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4550 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2672 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2005 | 604 | 0.010 |
Why?
|
| Metronidazole | 1 | 2001 | 231 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2002 | 544 | 0.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 265 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2013 | 5075 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9501 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1992 | 6414 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 1091 | 0.010 |
Why?
|
| Cataract Extraction | 1 | 2002 | 465 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 1612 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11071 | 0.010 |
Why?
|
| Vancomycin | 1 | 2001 | 503 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6898 | 0.010 |
Why?
|
| Anemia | 1 | 2007 | 1511 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2002 | 643 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4625 | 0.010 |
Why?
|
| Vero Cells | 1 | 1997 | 482 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2006 | 2688 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9631 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10827 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 36290 | 0.010 |
Why?
|
| Colon | 1 | 2001 | 1788 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15789 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 8056 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8651 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1988 | 777 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9585 | 0.000 |
Why?
|